
House dust mite (HDM) allergen-specific immunotherapy (AIT) improved small airway dysfunction (SAD) in asthmatic children over one year. FEF75 increased significantly from 49.55% to 71.89%, with 22 of 35 patients no longer exhibiting SAD. Basophil reactivity to HDM allergens decreased, and RNA sequencing revealed downregulation of immune-related genes and pathways, including those affecting Th2 cell differentiation.
Like
Save
Share